| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000016515 |
| Receipt No. | R000019174 |
| Scientific Title | A clinical study of bone regeneration using autologous dental pulp stem cells |
| Date of disclosure of the study information | 2015/02/12 |
| Last modified on | 2019/03/24 (Ver. 5) |
| Basic information | ||
| Public title | A clinical study of bone regeneration using autologous dental pulp stem cells | |
| Acronym | A clinical bone regeneration study with dental pulp stem cells | |
| Scientific Title | A clinical study of bone regeneration using autologous dental pulp stem cells | |
| Scientific Title:Acronym | A clinical bone regeneration study with dental pulp stem cells | |
| Region |
|
|
| Condition | |||
| Condition | Atrophy of alveolar bone | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To examine the safety and efficacy of bone regeneration by transplantation of autologous dental pulp stem cells. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Safety |
| Key secondary outcomes | Efficacy of bone regeneration |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Transplantation of dental pulp stem cells | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1)Patients who are capable of making an independent decision to comply with trial requirements and whose informed consents are obtained by oral and written document.
(2)Male and female (3)Age >=20-years-old and <=70-years-old (4)Patients who have unnecessary and/or discarded teeth such as wisdom tooth, expendientry extracted tooth for orthodontic treatment, supernumerary tooth or displaced tooth without occlusion to supply pulp tissue. (5)Patients who wish to have dental implant treatment rather than conventional removable prostheses or conserve teeth. (6)Patients who require bone transplantation for dental implant because of severe alveolar ridge atrophy. (The width of alveolar bone at the installation sites is <= 5 mm. In the maxilla, the distance between the alveolar ridge and the sinus floors is <= 5 mm. On the other hand, in the mandible the distance between the ridge and mandibular canal is<= 5 mm.) Finally it is decided by CT evaluation. (7)Patients that oral hygiene is well established. (8)Patients who are able to visit their hospitals in accordance with the trial schedule. |
|||
| Key exclusion criteria | (1)Patients who have a difficulty in collecting blood. (hemoglobin content < 11g/dl, blood platelet count <=100,000/mm3)
(2)Patients who suffer from infectious diseases (positive for HBs antigen, HBc antibody, HCV antibody, HIV antibody, HTLV-1 antibody, and syphilis serology). (3)Patients with coexisting disorder of the blood, circulatory system, kidney, and/or liver. (4)Patients taking anticoagulants or antiplatelet agents. (5)Patients with coexisting diabetes. (6)Patients with coexisting osteoporosis. (7)Patients who have mental or consciousness disorder, the history of dependence on alcohol or drugs. (8)Patients who are either pregnant, possibly pregnant, or who hope to become pregnant during the period of this trial. (9)Patients who have a previous history of allergy to any antimicrobial agent or local anesthesia. Others who the investigators determined as unsuitable for the trial. |
|||
| Target sample size | 10 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Aichi Medical University School of Medicine | ||||||
| Division name | Department of Oral and Maxillofacial Surgery | ||||||
| Zip code | |||||||
| Address | 1-1 Yazakokarimata, Nagakute, Aichi 480-1195 Japan | ||||||
| TEL | 0561-62-3311 | ||||||
| yyamada@aichi-med-u.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Aichi Medical University School of Medicine | ||||||
| Division name | Department of Oral and Maxillofacial Surgery | ||||||
| Zip code | |||||||
| Address | 1-1 Yazakokarimata, Nagakute, Aichi 480-1195 Japan | ||||||
| TEL | 0561-62-3311 | ||||||
| Homepage URL | |||||||
| yyamada@aichi-med-u.ac.jp | |||||||
| Sponsor | |
| Institute | Aichi Medical University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Aichi Medical University School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Cell Therapy Center of Biochemistry, Aichi Medical University School of Medicine |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 愛知医科大学病院(愛知県)Aichi Medical University Hospital(Aichi) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019174 |